Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SBB in connection with its sale to Brookfield
Mandate

Vinge advises SBB in connection with its sale to Brookfield

December 02, 2022 Capital Markets and Public M&A EU, Competition and Regulatory Real Estate and Construction Banking and Finance M&A Dispute Resolution

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with its sale of stake in its social infrastructure portfolio for public education to Brookfield for SEK 9.2 billion. The transaction also includes earn out payments up to SEK 1.2 billion.

SBB contributes its SEK 44.9 billion social infrastructure portfolio for public education to a newly formed SBB subsidiary EduCo AB (“EduCo”). Brookfield, one of the world’s largest infrastructure investors, through its open-ended core infrastructure fund (Brookfield Super-Core Infrastructure Partners), acquires a 49% minority stake in EduCo from SBB for approx. SEK 9.2 billion in cash up front, plus up to approx. SEK 1.2 billion in cash through earn-outs. EduCo will be operated and managed by SBB through an asset management agreement with respect to the management of the EduCo portfolio in its entirety.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl and Joel Wahlberg (Capital markets and Public M&A), Niclas Winnberg, Karolina Cohrs, Frida Ställborn, Kristoffer Larsson and Anette Kahn (Real Estate and Social Infrastructure), Albert Wållgren, Linn Adelwald and Axel Jansson (Financing), Maria Dahlin Kolvik and Sebastian Saadieh (M&A), Marcus Glader and Trine Osen Bergqvist (Competition and Regulatory) and Robert Wikholm (Restructuring and Insolvency).

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025